This cancer-testing stock is BTIG’s top pick after another major earnings beat
Investing.com -- BTIG has reaffirmed its bullish stance on Guardant Health (BIT:1GH), naming the cancer diagnostics company its "2026 Top Pick" after another quarterly revenue beat and an upgrade to its full-year outlook.
Investing.com -- BTIG has reaffirmed its bullish stance on Guardant Health (BIT:1GH), naming the cancer diagnostics company its "2026 Top Pick" after another quarterly revenue beat and an upgrade to its full-year outlook.
What's Your Reaction?
